Clin Exp Vaccine Res.
2021 Sep;10(3):301-303. 10.7774/cevr.2021.10.3.301.
Are the COVID-19’s vaccines efficient on the most dangerous variant of SARS-CoV-2?
- Affiliations
-
- 1Department of Molecular Medicine, University of Padua, Padua, Italy
- KMID: 2525836
- DOI: http://doi.org/10.7774/cevr.2021.10.3.301
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?
- SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
- COVID-19 and Breastfeeding
- SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed Individuals
- Changes in SARS-CoV-2 antibody titers 6 months after the booster dose of BNT162b2 COVID-19 vaccine among health care workers
